Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Tetra Bio-Pharma

Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback